Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEVG.L Regulatory News (EVG)

  • There is currently no data for EVG

Form 8.5 (EPT/RI)

1 Sep 2011 11:27

RNS Number : 4367N
Bank of America Merrill Lynch
01 September 2011
 



FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING

IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Name of exempt principal trader: Bank of America Merrill Lynch

(b) Name of offeror/offeree in relation to whose relevant securities this  Hansen Transmissions International NV

form relates:

(c) Name of the party to the offer with which exempt Advisor to Hansen Transmissions International NV

principal trader is connected:

(d) Date dealing undertaken: 31/08/2011

(e) Has the EPT previously disclosed, or is it today disclosing, under the NO

Code in respect of any other party to this offer?

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

(a) Purchases and sales

Class of Purchase/ Total number Highest price Lowest price

relevant Sales of securities per unit per unit

security paid/received paid/received

Common - BE0947727377 Purchase 11,884 GBP 0.64 GBP 0.64

Common - BE0947727377 Sale 18,730 GBP 0.65 GBP 0.64

(b) Derivatives transactions (other than options)

Class of Product description   Nature of dealing Number of reference   Price per unit

relevant eg. CFD securities

security

Common - BE0947727377 Swap SHORT 8549 GBP 0.64

Common - BE0947727377 Swap SHORT 2081 GBP 0.64

Common - BE0947727377 Swap SHORT 529 GBP 0.64

Common - BE0947727377 Swap SHORT 439 GBP 0.64

Common - BE0947727377 Swap SHORT 286 GBP 0.64

Class of Product description   Nature of dealing Number of reference   Price per unit

relevant eg. CFD securities

security

Common - BE0947727377 Swap LONG 2637 GBP 0.64

Common - BE0947727377 Swap LONG 16093 GBP 0.64

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of Product Writing, Number of Exercise Type Expiry Option

relevant description purchasing, securities price date money

security selling, to which per unit paid/

varying etc. option received

relates per unit

(ii) Exercising

Class of relevant security Product description Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing Details Price per unit (if applicable)

3. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding,

formal or informal, relating to relevant securities which may be an inducement to deal

or refrain from dealing entered into by the exempt principal trader making the

disclosure and any party to the offer or any person acting in concert with a party to the

offer:

NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between

the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which

any derivative is referenced:

NONE

Date of disclosure: 01/09/2011

Contact name: Doug Berwick

Telephone number: +44 20 7995 8859

 

 

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING

IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Name of exempt principal trader: Bank of America Merrill Lynch

(b) Name of offeror/offeree in relation to whose relevant securities this INVESTEC PLC

form relates:

(c) Name of the party to the offer with which exempt Advisor to INVESTEC PLC and INVESTEC LTD

principal trader is connected:

(d) Date dealing undertaken: 31/08/2011

(e) Has the EPT previously disclosed, or is it today disclosing, under the NO

Code in respect of any other party to this offer?

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

(a) Purchases and sales

Class of Purchase/ Total number Highest price Lowest price

relevant Sales of securities per unit per unit

security paid/received paid/received

Common - GB00B17BBQ50 Purchase 53,695 GBP 48.76 GBP 4.28

Common - GB00B17BBQ50 Sale 55,357 GBP 49.49 GBP 4.20

(b) Derivatives transactions (other than options)

Class of Product description   Nature of dealing Number of reference   Price per unit

relevant eg. CFD securities

security

Common - GB00B17BBQ50 Swap SHORT 252 GBP 4.25

Common - GB00B17BBQ50 Swap SHORT 78 GBP 4.29

Common - GB00B17BBQ50 Swap SHORT 30870 GBP 4.28

Common - GB00B17BBQ50 Swap SHORT 2896 GBP 4.28

Common - GB00B17BBQ50 Swap SHORT 2000 GBP 4.29

Common - GB00B17BBQ50 Swap SHORT 719 GBP 4.28

Common - GB00B17BBQ50 Swap SHORT 9679 GBP 4.29

Class of Product description   Nature of dealing Number of reference   Price per unit

relevant eg. CFD securities

security

Common - GB00B17BBQ50 Swap LONG 800 GBP 4.19

Common - GB00B17BBQ50 Swap LONG 6758 GBP 4.32

Common - GB00B17BBQ50 Swap LONG 246314 GBP 0.00

Common - GB00B17BBQ50 Swap LONG 64659 GBP 0.00

Common - GB00B17BBQ50 Swap LONG 30870 GBP 0.00

Common - GB00B17BBQ50 Swap LONG 3025 GBP 0.00

Common - GB00B17BBQ50 Swap LONG 844 GBP 4.19

Common - GB00B17BBQ50 Swap LONG 252 GBP 2.27

Common - GB00B17BBQ50 Swap LONG 259 GBP 4.19

Common - GB00B17BBQ50 Swap LONG 138 GBP 4.23

Common - GB00B17BBQ50 Swap LONG 132 GBP 0.00

Common - GB00B17BBQ50 Swap LONG 14 GBP 4.21

Common - GB00B17BBQ50 Swap LONG 33514 GBP 4.27

Common - GB00B17BBQ50 Swap LONG 719 GBP 4.27

Common - GB00B17BBQ50 Swap LONG 2896 GBP 4.26

Common - GB00B17BBQ50 Swap LONG 600 GBP 4.29

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of Product Writing, Number of Exercise Type Expiry Option

relevant description purchasing, securities price date money

security selling, to which per unit paid/

varying etc. option received

relates per unit

(ii) Exercising

Class of relevant security Product description Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing Details Price per unit (if applicable)

3. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding,

formal or informal, relating to relevant securities which may be an inducement to deal

or refrain from dealing entered into by the exempt principal trader making the

disclosure and any party to the offer or any person acting in concert with a party to the

offer:

NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between

the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which

any derivative is referenced:

NONE

Date of disclosure: 01/09/2011

Contact name: Doug Berwick

Telephone number: +44 20 7995 8859

 

 

 

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING

IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Name of exempt principal trader: Bank of America Merrill Lynch

(b) Name of offeror/offeree in relation to whose relevant securities this Evolution Group Plc

form relates:

(c) Name of the party to the offer with which exempt Advisor to INVESTEC PLC and INVESTEC LTD

principal trader is connected:

(d) Date dealing undertaken: 31/08/2011

(e) Has the EPT previously disclosed, or is it today disclosing, under the NO

Code in respect of any other party to this offer?

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

(a) Purchases and sales

Class of Purchase/ Total number Highest price Lowest price

relevant Sales of securities per unit per unit

security paid/received paid/received

Common - GB0030221864 Purchase 2,288 GBP 0.92 GBP 0.92

(b) Derivatives transactions (other than options)

Class of Product description   Nature of dealing Number of reference   Price per unit

relevant eg. CFD securities

security

Common - GB0030221864 Swap SHORT 1693 GBP 0.92

Common - GB0030221864 Swap SHORT 595 GBP 0.92

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of Product Writing, Number of Exercise Type Expiry Option

relevant description purchasing, securities price date money

security selling, to which per unit paid/

varying etc. option received

relates per unit

(ii) Exercising

Class of relevant security Product description Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing Details Price per unit (if applicable)

3. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding,

formal or informal, relating to relevant securities which may be an inducement to deal

or refrain from dealing entered into by the exempt principal trader making the

disclosure and any party to the offer or any person acting in concert with a party to the

offer:

NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between

the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which

any derivative is referenced:

NONE

Date of disclosure: 01/09/2011

Contact name: Doug Berwick

Telephone number: +44 20 7995 8859

 

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING

IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Name of exempt principal trader: Bank of America Merrill Lynch

(b) Name of offeror/offeree in relation to whose relevant securities this Autonomy Corporation Plc

form relates:

(c) Name of the party to the offer with which exempt Advisor to Autonomy Corporation Plc

principal trader is connected:

(d) Date dealing undertaken: 31/08/2011

(e) Has the EPT previously disclosed, or is it today disclosing, under the NO

Code in respect of any other party to this offer?

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

(a) Purchases and sales

Class of Purchase/ Total number Highest price Lowest price

relevant Sales of securities per unit per unit

security paid/received paid/received

Common - GB0055007982 Purchase 108,803 GBP 25.20 GBP 25.13

Common - GB0055007982 Sale 95,689 GBP 25.20 GBP 25.13

(b) Derivatives transactions (other than options)

Class of Product description   Nature of dealing Number of reference   Price per unit

relevant eg. CFD securities

security

Common - GB0055007982 Swap SHORT 8913 GBP 25.18

Common - GB0055007982 Swap SHORT 5674 GBP 25.17

Common - GB0055007982 Swap SHORT 3450 GBP 25.18

Common - GB0055007982 Swap SHORT 388 GBP 25.15

Common - GB0055007982 Swap SHORT 337 GBP 25.17

Common - GB0055007982 Swap SHORT 307 GBP 25.13

Common - GB0055007982 Swap SHORT 276 GBP 25.13

Class of Product description   Nature of dealing Number of reference   Price per unit

relevant eg. CFD securities

security

Common - GB0055007982 Swap LONG 243 GBP 25.19

Common - GB0055007982 Swap LONG 388 GBP 25.20

Common - GB0055007982 Swap LONG 565 GBP 25.19

Common - GB0055007982 Swap LONG 628 GBP 25.19

Common - GB0055007982 Swap LONG 779 GBP 25.13

Common - GB0055007982 Swap LONG 1478 GBP 25.15

Common - GB0055007982 Swap LONG 2465 GBP 25.18

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of Product Writing, Number of Exercise Type Expiry Option

relevant description purchasing, securities price date money

security selling, to which per unit paid/

varying etc. option received

relates per unit

(ii) Exercising

Class of relevant security Product description Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing Details Price per unit (if applicable)

3. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding,

formal or informal, relating to relevant securities which may be an inducement to deal

or refrain from dealing entered into by the exempt principal trader making the

disclosure and any party to the offer or any person acting in concert with a party to the

offer:

NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between

the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which

any derivative is referenced:

NONE

Date of disclosure: 01/09/2011

Contact name: Doug Berwick

Telephone number: +44 20 7995 8859

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERBFLFBFKFLBBE
Date   Source Headline
13th Dec 20177:00 amRNSCollaboration with King's College London
11th Dec 20177:15 amRNSHardman Res.: Funded to the end of Phase II trials
8th Dec 20177:15 amRNSPlacing and Notice of General Meeting
8th Dec 20177:00 amRNSInterim Results
23rd Nov 201711:05 amRNSSecond Price Monitoring Extn
23rd Nov 201711:00 amRNSPrice Monitoring Extension
4th Oct 20177:00 amRNSFirst European Patent Grant
31st Aug 20177:00 amRNSIssue of Equity and Total Voting Rights
2nd Aug 20171:00 pmRNSSFX-01 data published in Peer Reviewed Journal
27th Jul 20177:00 amRNSResult of AGM
26th Jul 20177:00 amRNSAGM Statement
11th Jul 201712:30 pmRNSCharity-funded Study of SFX-01 in TNBC
21st Jun 201710:00 amRNSPosting of Annual Report and AGM Notice
21st Jun 20177:15 amRNSHardman Research: Making clinical progress
13th Jun 20177:00 amRNSFull Year Results
1st Jun 20177:00 amRNSCompassionate Use Programme and Trials Update
25th May 20177:00 amRNSNotice of Preliminary Results
3rd Apr 20172:15 pmRNSDirectorate Change
28th Mar 20172:45 pmRNSFurther US Patent Grant
6th Mar 20177:00 amRNSIssue of Equity, PDMR Shareholding and TVR
14th Feb 20171:30 pmRNSPatent Grant in the United States
13th Feb 20177:00 amRNSServices Agreement with APTrans
17th Jan 20177:00 amRNSFirst Patient Dosed in Breast Cancer Trial
17th Jan 20177:00 amRNSAppointment of CFO and Head of Clinical Operations
11th Jan 20177:00 amRNSPositive DSMB Review of SAS Trial
5th Dec 20167:00 amRNSHalf Yearly Report
29th Nov 201611:53 amRNSHardman Research: Clinical sulforaphane potential
17th Nov 20167:00 amRNSNotice of Interim Results
1st Nov 201612:30 pmRNSGrant of Options
15th Sep 20167:00 amRNSUpdate re SFX-01 Data at ECTRIMS 2016
8th Sep 20163:30 pmRNSPresentation of SFX-01 Data at ECTRIMS 2016
24th Aug 20163:15 pmRNSOrphan Designation in the USA in SAH
17th Aug 20167:00 amRNSApproval for Phase II Study in Breast Cancer
24th Jun 20163:36 pmRNSResult of AGM
9th Jun 20167:00 amRNSGrant of Options
2nd Jun 20167:00 amRNSPosting of Annual Report and AGM Notice
31st May 20167:00 amRNSFinal Results
9th May 20167:00 amRNSNotification of Preliminary Results
3rd May 20167:00 amRNSFirst Patient Dosed in Phase II Trial
2nd Mar 20167:00 amRNSApproval of Phase II Clinical Trial in SAH
19th Jan 20163:23 pmRNSCorrection: Director Share Purchases
19th Jan 20167:00 amRNSDirector Share Purchases
11th Jan 20167:00 amRNSExercise of Options
4th Jan 20167:00 amRNSAppoints Chief Medical Officer
7th Dec 20157:00 amRNSHalf Yearly Report
23rd Nov 20157:00 amRNSExpands Pipeline with Novel Compounds
16th Nov 20157:00 amRNSNotification of Half Year Results
23rd Oct 201511:45 amRNSNotification of Major Interest in Shares
21st Oct 20157:00 amRNSFirst Day of Dealings
21st Dec 20114:30 pmRNSTemporary Suspension Evolution Group PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.